Inspire Medical Systems, Inc. (INSP) research
Inspire Medical Systems, Inc.- Sector
- Health Care
- Last price
- $69.97
- As of
Inspire Medical Systems, Inc. (INSP): 4 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-08-03.
As of . Source: SEC EDGAR filings for INSP. Method and limitations.
Share the INSP intelligence card
See the full INSP dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for INSP on one page. Preview it with sample data, then open it live with a free account.
Preview the INSP dossierActive signals for INSP
- highINSTITUTIONAL_EXIT
MILLENNIUM MANAGEMENT LLC cut 76% of INSP (2026Q2)
- highINSTITUTIONAL_SURGE
CITADEL ADVISORS LLC added +1334% to INSP (2026Q2)
- highINSTITUTIONAL_SURGE
D. E. Shaw & Co., Inc. added +13147% to INSP (2026Q2)
- mediumEARNINGS_BEAT
Q2-2026: Beat consensus by 150.7%, EPS $0.14 vs $-0.2764 estimate
- mediumEARNINGS_BEAT
Q3-2025: Beat consensus by 271.7% - EPS $0.34 vs $-0.198 estimate
FREE, NO ACCOUNT
Every signal on INSP, as it fires
You are seeing 5 of 9 signals recorded on INSP since 2026-05-29.
The five above landed across 3 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in INSP (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| D. E. Shaw & Co., Inc.CUSIP 457730109 · 2026Q2 | $65.6M | 0.03% | , |
| CITADEL ADVISORS LLCCUSIP 457730109 · 2026Q2 | $22.6M | 0.00% | , |
| RENAISSANCE TECHNOLOGIES LLCCUSIP 457730109 · 2026Q2 | $19M | 0.03% | , |
| MILLENNIUM MANAGEMENT LLCCUSIP 457730109 · 2026Q2 | $4.2M | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, INSP
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 10-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
INSP against its peers
INSP's operating margin of 5.6% ranks in the 62nd percentile of 24 Health Care sub-industry peers, fiscal periods ending between 2025-12-31 and 2026-01-03.
| Metric | INSP | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 912M USD | 1.0B USD | 44 | 25 |
| Gross margin | 85.4% | 54.6% | 97 | 17 |
| Operating margin | 5.6% | 1.0% | 62 | 24 |
| Net margin | 15.9% | -0.0% | 90 | 25 |
| Return on equity | 18.6% | 0.0% | 86 | 24 |
| P / E | 14.3x | 36.4x | 21 | 11 |
Peers (25): SEM, PGNY, MD, LMAT, WGS, NVCR, XRAY, ALHC, PRVA, ATEC, ACHC, BKD, OMCL, AVAH, CERT, ATRC, CNMD, TMDX, AMN, PNTG, USPH, OMDA, TNDM, STAA, GDRX. Fiscal periods ending between 2025-12-31 and 2026-01-03. Every figure is one full fiscal year read from one annual filing (INSP: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
See more INSP signals as they fire
Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to INSPand get the insider, 13F, options, and confluence read in one view.